Global High-Priority Regulatory Events — February 22, 2026

23-02-2026

23-02-2026

23-02-2026

Agribio Spirits Ltd (BSE: 539546) promoters have submitted disclosures of reasons for encumbrance under SEBI (SAST) Regulations, 2011 - Reg. 31(1) read with Regulation 28(3). The disclosure was received by BSE on February 23, 2026. No quantitative details such as share volume, transaction value, percentage of holding, pledge type (creation or reduction), or specific reasons are provided in the filing.

23-02-2026

23-02-2026

MoonLake Immunotherapeutics filed a Form 8-K on February 23, 2026 (AccNo: 0001213900-26-018967), reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing indicating several material corporate developments, but specific transaction details, financial metrics, dollar values, and impacts are NOT_DISCLOSED. No quantitative data, period-over-period comparisons, or named entities beyond the filer are provided.

23-02-2026

Generation Income Properties, Inc. filed an 8-K on February 23, 2026 (AccNo: 0001193125-26-064001), disclosing under Item 2.01 the completion of an acquisition or disposition of assets. No details on transaction parties, structure, value, or financial terms were provided. Sector was not specified.

23-02-2026

I-ON Digital Corp. filed a Form 8-K on February 23, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits attached under Item 9.01. No quantitative details such as transaction values, share counts, or financial impacts are disclosed. This multi-item filing highlights potentially significant corporate actions but lacks specifics on positive or negative implications.

23-02-2026

23-02-2026

23-02-2026

23-02-2026

23-02-2026

Ingevity Corp filed an 8-K on 2026-02-23 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, timing, or quantitative impacts are disclosed.

23-02-2026

AppTech Payments Corp. filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 includes Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed.

23-02-2026

CenterPoint Energy Inc. filed an 8-K on February 23, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or impacts are provided in the filing summary. Sector information is not specified.

23-02-2026

Barinthus Biotherapeutics plc filed an 8-K on 2026-02-23 reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, financial metrics, positive or negative impacts, or quantitative data are provided in the filing summary.

23-02-2026

Artificial Intelligence Technology Solutions Inc. filed an 8-K on February 23, 2026, reporting under Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the modifications, amendments, disclosures, or exhibits are provided, resulting in no quantifiable positive or negative metrics. This multi-item filing appears informational without disclosed financial or operational impacts.

23-02-2026

Entravision Communications Corp filed an 8-K on February 23, 2026 (AccNo: 0001193125-26-061961), disclosing an officer change under Item 5.02 covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, names, reasons for change, timing, or any quantitative metrics are disclosed.

23-02-2026

BullFrog AI Holdings, Inc. filed an 8-K on 2026-02-23 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, with potential transfer of listing. Item 9.01 reports financial statements and exhibits. No quantitative financial metrics, transaction values, or further details on the delisting rationale or impacts are disclosed.

23-02-2026

K2 Capital Acquisition Corp filed an 8-K on 2026-02-23 under Item 8.01 Other Events announcing a Merger/Acquisition. No specific deal structure, parties involved, valuation, financial terms, or other quantitative details are disclosed in the provided filing metadata. Sector is not specified, and no positive or negative metrics are mentioned.

23-02-2026

Illinois Tool Works Inc filed a multi-item 8-K on February 23, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 1.02 termination of a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 9.01 financial statements and exhibits. The filing reflects both new commitments and the end of prior ones alongside additional financial obligations. No specific transaction details, values, or impacts are disclosed.

23-02-2026

Carlyle Secured Lending, Inc. filed an 8-K on 2026-02-23 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the affected position, individuals involved, reasons for the change, or any quantitative metrics are disclosed. No positive or negative performance metrics are mentioned.

23-02-2026

Ovintiv Inc. filed an 8-K on February 23, 2026, disclosing under Item 1.01 its entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits, likely including the agreement document. No specific terms, values, financial impacts, or other metrics are disclosed in the available filing summary.

23-02-2026

23-02-2026

Shorepower Technologies Inc. filed an 8-K on February 23, 2026, announcing completion of an acquisition or disposition of assets (Item 2.01), unregistered sales of equity securities (Item 3.02), changes in control of the registrant (Item 5.01), departures/elections/appointments of directors and officers with compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03). Item 9.01 includes financial statements and exhibits. No specific deal terms, financial metrics, parties involved, or quantitative impacts are disclosed.

23-02-2026

23-02-2026

Miluna Acquisition Corp filed an 8-K on 2026-02-23 disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, dates, terms, financial details, or transaction-related information are provided in the filing summary. No quantitative metrics, positive or negative changes, or merger/acquisition details are mentioned.

23-02-2026

Gilead Sciences, Inc. filed an 8-K on 2026-02-23 reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No details on the nature of the agreement, transaction value, financial impacts, or other quantitative metrics are disclosed. This is a multi-item mandatory filing for Items 1.01 and 9.01 with Item 7.01 often accompanying forward-looking disclosures.

• ·AccNo: 0001104659-26-018314

23-02-2026

Zura Bio Ltd filed an 8-K on 2026-02-23 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officers, reasons for change, or compensatory arrangements are provided in the available information. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

23-02-2026

PENN Entertainment, Inc. filed a Form 8-K on 2026-02-23 disclosing entry into a material definitive agreement (Item 1.01), departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). This is a multi-item filing with no specific details on the agreement, personnel changes, disclosures, or financial impacts provided in the summary. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.

23-02-2026

Foghorn Therapeutics Inc. filed an 8-K on 2026-02-23 disclosing officer or director changes, including departures, elections, appointments, or compensatory arrangements under Item 5.02, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the affected positions, names, reasons for changes, timing, or any quantitative metrics such as compensation amounts or share counts are explicitly stated. This is an informational filing with all key leadership change details NOT_DISCLOSED.

23-02-2026

Coronado Global Resources Inc. filed an 8-K on 2026-02-23 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, appointment or resignation status, reasons, timing, or any quantitative metrics are provided. No positive or negative governance implications, board outcomes, or succession signals can be assessed due to lack of disclosed information.

23-02-2026

ADC Therapeutics SA filed a Form 8-K on February 23, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with exhibits under Item 9.01. No specific details on the agreement terms, transaction value, share counts, or financial impacts are provided in the filing summary. This represents a multi-item mandatory disclosure with no quantitative metrics or performance comparisons disclosed.

23-02-2026

United Homes Group, Inc. filed a Form 8-K on 2026-02-23 reporting entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, along with Regulation FD disclosure under Item 7.01 and financial statements/exhibits under Item 9.01. No quantitative financial metrics, transaction values, positive or negative performance indicators, or period-over-period comparisons are disclosed. This is a multi-item informational filing with no specified directional impacts.

23-02-2026

Resolute Holdings Management, Inc. filed a Form 8-K on February 23, 2026, disclosing under Item 1.01 entry into a new material definitive agreement, under Item 1.02 termination of a prior material definitive agreement, and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. No specific details on the nature of the agreements, transaction values, parties involved, or financial terms were provided. This multi-item filing signals significant contractual changes including both a new commitment and termination of an existing one, but lacks quantification of impacts.

23-02-2026

Real Asset Acquisition Corp. filed an 8-K on February 23, 2026, disclosing entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01 related to a merger/acquisition event. No specific deal structure, parties, valuation, financial metrics, synergies, or impacts were disclosed in the provided filing summary. No quantitative data, comparisons, or scheduled events were mentioned.

23-02-2026

GameSquare Holdings, Inc. filed a Form 8-K on February 23, 2026, disclosing multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, financial metrics, or quantitative impacts provided. No positive or negative performance metrics are disclosed.

23-02-2026

CULP INC filed an 8-K on 2026-02-23 reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, along with transfer of listing implications. Item 7.01 discloses Regulation FD information, and Item 9.01 lists financial statements and exhibits. No financial metrics, transaction values, or period-over-period comparisons were disclosed.

23-02-2026

Candel Therapeutics, Inc. filed an 8-K on February 23, 2026, disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction value, financial impacts, or events were provided in the filing summary. This is a multi-item mandatory disclosure with no quantitative metrics or directional indicators disclosed.

23-02-2026

VisionWave Holdings, Inc. filed an 8-K on 2026-02-23 disclosing entry into a Material Definitive Agreement under Item 1.01, with Financial Statements and Exhibits attached under Item 9.01. This is a multi-item filing with no specific transaction details, dollar values, parties, or financial impacts provided in the summary. No quantitative metrics, positive or negative changes, or period-over-period comparisons were disclosed.

23-02-2026

Atara Biotherapeutics, Inc. filed a Form 8-K on 2026-02-23 reporting under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory disclosure filing with no specific transaction details, dollar values, share counts, financial metrics, or period-over-period comparisons provided. No positive or negative metrics are disclosed, preventing assessment of financial impacts or strategic outcomes.

23-02-2026

Verisk Analytics, Inc. filed a Form 8-K on February 23, 2026, reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, or disclosures provided in the summary. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.

23-02-2026

Lakeland Industries Inc filed an 8-K on February 23, 2026 (AccNo: 0001193125-26-062550), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on affected positions, appointment/resignation status, reasons, or quantitative metrics are disclosed in the provided information.

23-02-2026

Fortress Biotech, Inc. filed an 8-K on February 23, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 8.01 reports other events, and Item 9.01 lists financial statements and exhibits. No specific transaction values, financial impacts, or quantitative metrics are disclosed.

23-02-2026

Pelican Acquisition Corp filed an 8-K on February 23, 2026 (AccNo: 0001829126-26-001553), disclosing information under Item 7.01 Regulation FD Disclosure and providing exhibits under Item 9.01 Financial Statements and Exhibits, related to a merger/acquisition event. No specific deal structure, parties, valuation, financial metrics, synergies, or timelines were explicitly stated in the provided filing summary. Sector details are not specified.

23-02-2026

BrightSpire Capital, Inc. filed a Form 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific transaction details, dollar values, or quantitative impacts disclosed in the provided information. No positive or negative metrics, period-over-period comparisons, or guidance changes are mentioned.

23-02-2026

23-02-2026

Sturm Ruger & Co Inc filed an 8-K on 2026-02-23 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or any quantitative metrics are disclosed. No positive or negative performance metrics are mentioned.

23-02-2026

Cannabist Co Holdings Inc. filed a Form 8-K on 2026-02-23 under Item 1.01 disclosing entry into a material definitive agreement. No details on the agreement's parties, terms, dollar value, strategic rationale, or financial impacts are provided in the available information. No quantitative metrics, comparisons, or scheduled events are mentioned.

• ·Accession Number: 0001776738-26-000006
• ·File Size: 131 KB
• ·Single-item filing (Item 1.01 only)

23-02-2026

TRANSUITE.ORG INC. filed a Form 8-K on 2026-02-23 under Item 1.01 disclosing entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits. No details on the agreement terms, counterparties, value, or financial impacts are disclosed.

23-02-2026

Avenue Therapeutics, Inc. filed an 8-K on 2026-02-23 reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction terms, financial metrics, positive or negative impacts, or other quantitative data are disclosed.

23-02-2026

Spring Valley Acquisition Corp. II filed an 8-K on 2026-02-23 under Item 5.07 disclosing submission of matters to a vote of security holders. No specific details on the matters submitted, vote outcomes, participating parties, or any quantitative metrics are explicitly stated in the filing summary provided. No positive or negative performance metrics, financial data, or transaction terms are mentioned.

23-02-2026

NEXTNRG, INC. filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed.

23-02-2026

Arcellx, Inc. filed a Form 8-K on 2026-02-23 disclosing entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details provided on the agreement's nature, parties, terms, dollar value, or financial impacts. No quantitative metrics, period-over-period comparisons, positive or negative changes, or scheduled events are mentioned.

23-02-2026

NI Holdings, Inc. filed a Form 8-K on 2026-02-23 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, positions affected, reasons for the change, timing details, or financial terms are disclosed in the provided filing summary. This is a standard governance disclosure without additional quantitative or qualitative details.

23-02-2026

Phreesia, Inc. filed an 8-K on February 23, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. No specific details on the affected officer position, appointment or resignation status, reasons, or financial impacts are provided. The event is categorized as an Officer Change with no quantitative metrics or performance comparisons disclosed.

23-02-2026

INFINITY NATURAL RESOURCES, INC. filed an 8-K on 2026-02-23 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), alongside creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), departures/elections of directors/officers and compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03). Regulation FD disclosure was also provided (Item 7.01) with financial statements and exhibits (Item 9.01). No quantitative metrics, deal values, parties involved, synergies, or performance comparisons were explicitly stated.

23-02-2026

Digital Asset Acquisition Corp. filed an 8-K on February 23, 2026 (AccNo: 0001213900-26-019337) disclosing information under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits, related to a merger/acquisition event. No specific deal structure, parties, valuation, financial metrics, or other quantitative details are disclosed in the provided filing information. Sector is not specified.

23-02-2026

AeroVironment Inc filed an 8-K on 2026-02-23 disclosing matters under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 9.01 references Financial Statements and Exhibits. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative metrics are provided.

23-02-2026

BellRing Brands, Inc. filed an 8-K on February 23, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative impacts are provided in the filing summary. No financial metrics, performance comparisons, or other material changes are mentioned.

23-02-2026

Aethlon Medical Inc. filed an 8-K on February 23, 2026 (AccNo: 0001683168-26-001259), disclosing events under Items 5.02, 5.03, 5.07, and 9.01. Item 5.02 covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Items 5.03 and 5.07 address amendments to articles of incorporation or bylaws/change in fiscal year and submission of matters to a vote of security holders, respectively; no specific details, metrics, or outcomes are disclosed.

23-02-2026

Cleveland-Cliffs Inc. filed an 8-K on 2026-02-23 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or quantitative impacts are disclosed. No positive or negative metrics are mentioned.

23-02-2026

Functional Brands Inc. filed an 8-K on 2026-02-23 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, personnel changes, transaction values, dollar amounts, percentages, or financial impacts are disclosed in the provided filing summary. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

23-02-2026

Sharps Technology Inc. filed an 8-K on February 23, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 5.02 matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details, transaction values, dollar amounts, names of individuals or counterparties, financial impacts, or quantitative metrics were provided in the filing summary. This represents a multi-item mandatory filing with unknown implications due to lack of disclosed substance.

23-02-2026

Compass, Inc. filed an 8-K on 2026-02-23 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or any quantitative metrics are disclosed. Sector information is not specified.

23-02-2026

SI-BONE, Inc. filed a Form 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.02 results of operations and financial condition, and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. This is a multi-item filing covering significant corporate, financial, and personnel developments. No specific transaction details, financial metrics, personnel names, dollar values, or performance comparisons are disclosed.

23-02-2026

Sixth Street Specialty Lending, Inc. filed an 8-K on 2026-02-23 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). Specific details including the key position affected, name of the officer, reason for change, or any financial metrics are NOT_DISCLOSED. No quantitative data, performance metrics, or scheduled events are provided in the available information.

23-02-2026

Angel Studios, Inc. filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement. No specific details regarding the agreement's terms, parties, dollar value, or financial impacts are disclosed in the filing summary. No quantitative metrics, positive or negative changes, or operational effects are mentioned.

23-02-2026

VEEA INC. filed an 8-K on February 23, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 lists financial statements and exhibits. No transaction details, dollar values, parties involved, financial impacts, or other metrics are disclosed.

23-02-2026

Houston American Energy Corp filed an 8-K on February 23, 2026 (AccNo: 0001493152-26-007761), reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No quantitative details such as transaction values, share counts, dollar amounts, or financial impacts were disclosed. This multi-item filing indicates potential strategic or financing developments but provides no specifics for impact assessment.

• ·File size: 932 KB
• ·Multi-item mandatory 8-K filing

23-02-2026

DHI Group, Inc. filed an 8-K on February 23, 2026 (AccNo: 0001393883-26-000045, Size: 227 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or any named individuals are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

23-02-2026

NATIONAL HEALTH INVESTORS INC filed an 8-K on 2026-02-23 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details on positions affected, names, reasons for change, or quantitative metrics are disclosed.

23-02-2026

Invest Green Acquisition Corp announced entry into a Material Definitive Agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03 in its 8-K filing dated February 23, 2026. Item 9.01 includes financial statements and exhibits. No specific transaction details, financial metrics, parties involved, or quantitative impacts are disclosed.

23-02-2026

Martin Marietta Materials Inc. filed an 8-K on 2026-02-23 announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific transaction details, financial metrics, parties involved, or quantitative impacts are disclosed.

23-02-2026

Flowers Foods Inc. filed an 8-K on 2026-02-23 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key position affected, individual names, appointment or resignation status, reasons for change, or financial metrics are disclosed. No positive or negative performance metrics, period-over-period comparisons, or quantitative data provided.

23-02-2026

Boston Scientific Corp filed an 8-K on February 23, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also covers Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, timing, or any financial metrics are disclosed.

• ·AccNo: 0000885725-26-000013
• ·File size: 254 KB
• ·Sector: NOT_DISCLOSED

23-02-2026

Lunai Bioworks Inc. filed a Form 8-K on 2026-02-23 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, transaction values, dollar impacts, or additional details such as reasons for delisting, effective dates, or exchange involved were disclosed. This represents a material negative event with no offsetting positive information provided.

• ·AccNo: 0001731122-26-000282
• ·Filing size: 190 KB
• ·Sector: NOT_DISCLOSED

23-02-2026

STONERIDGE INC filed an 8-K on February 23, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details such as the key position affected, names, appointment or resignation status, reasons, or timing are NOT_DISCLOSED. No quantitative metrics, financial data, scheduled events, or further context provided in the filing summary.

23-02-2026

Reborn Coffee, Inc. filed an 8-K on 2026-02-23 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No financial metrics, transaction values, or quantitative impacts were disclosed in the provided filing summary. This represents a multi-item filing focused on significant regulatory and leadership events.

23-02-2026

EQV Ventures Acquisition Corp. filed an 8-K on 2026-02-23 under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits related to a merger/acquisition event. No quantitative metrics, period-over-period comparisons, deal structure details, parties involved, valuation, synergies, regulatory pathways, or shareholder impacts were explicitly stated in the filing summary. This filing appears informational with all key transaction specifics NOT_DISCLOSED.

23-02-2026

Alpha Cognition Inc. filed an 8-K on February 23, 2026 (AccNo: 0001213900-26-019355), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or any board composition impacts are NOT_DISCLOSED. No quantitative financial metrics, scheduled events, or governance implications are mentioned.

• ·Filing size: 190 KB
• ·Sector: not specified

23-02-2026

Village Farms International, Inc. filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction size, financial metrics, positive or negative impacts, or other quantitative data are disclosed in the provided filing information. This is a multi-item filing with no period-over-period comparisons or named entities beyond the filer mentioned.

23-02-2026

Algorhythm Holdings, Inc. filed a multi-item Form 8-K on February 23, 2026, reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). No specific transaction values, terms, financial impacts, or quantitative metrics were disclosed. This filing appears informational without detailed positive or negative elements.

23-02-2026

Ecolab Inc. filed an 8-K on February 23, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Specific details including the key position affected, the officer's name, whether it is an appointment or resignation, reasons for the change, and any timing or succession information are NOT_DISCLOSED. No quantitative data, financial metrics, or further governance implications are provided in the filing summary.

23-02-2026

iSpecimen Inc. filed an 8-K on 2026-02-23 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative data are provided in the filing summary. This represents a standard SEC-required disclosure with no additional context on implications.

23-02-2026

International Battery Metals Ltd. filed a Form 8-K on February 23, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, accompanied by exhibits under Item 9.01. This multi-item mandatory filing highlights significant corporate actions, where the material agreement represents a potentially strategic development while the unregistered equity sales introduce potential shareholder dilution. No specific transaction values, financial impacts, or other quantitative details are provided.

23-02-2026

Oncology Institute, Inc. filed an 8-K on 2026-02-23 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. Specific details including the key position affected, appointment or resignation status, reasons for the change, and any quantitative data are NOT_DISCLOSED. No positive or negative metrics, financial impacts, or board composition changes are mentioned.

23-02-2026

Westlake Corp filed an 8-K on 2026-02-23 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected position, whether it is an appointment or resignation, reasons for the change, or any named individuals are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or governance impacts are provided in the available information.

23-02-2026

Westlake Chemical Partners LP filed an 8-K on February 23, 2026 (AccNo: 0001193125-26-064229), under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative financial impacts are disclosed. No positive or negative metrics, board outcomes, or governance implications are specified.

23-02-2026

BRC Inc. filed an 8-K on February 23, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details including names, positions, reasons for changes, timing, or compensation amounts are disclosed.

• ·AccNo: 0001891101-26-000014
• ·File Size: 151 KB
• ·Sector: NOT_DISCLOSED

23-02-2026

Twin Vee PowerCats, Co. filed a Form 8-K on February 23, 2026 (AccNo: 0001731122-26-000283), reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory disclosure with no specific details provided on the agreement, events, transaction terms, financial impacts, or metrics. No quantitative data, period-over-period comparisons, positive or negative metrics, or scheduled events are disclosed.

23-02-2026

Enhabit, Inc. filed a Form 8-K on 2026-02-23 disclosing entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing for the material agreement, but specific details on the agreement's nature, parties, dollar value, strategic importance, or financial impacts are NOT_DISCLOSED. No quantitative metrics, period-over-period comparisons, guidance changes, or scheduled events are mentioned.

23-02-2026

HCM IV Acquisition Corp. filed an 8-K on 2026-02-23 (AccNo: 0001213900-26-019378, Size: 413 KB) under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) in connection with a Merger/Acquisition event. No quantitative metrics, deal terms, parties, strategic rationale, or performance comparisons (positive, negative, or flat) are explicitly stated. All key details including valuation, structure, and impacts remain NOT_DISCLOSED.

23-02-2026

Better Home & Finance Holding Co filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits. No specific details including transaction value, parties, terms, financial impacts, or strategic context are disclosed.

23-02-2026

Mueller Water Products, Inc. filed an 8-K on 2026-02-23 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided in the available information. No quantitative metrics, financial impacts, or performance comparisons are mentioned.

23-02-2026

Keurig Dr Pepper Inc. filed a Form 8-K on 2026-02-23 (AccNo: 0001193125-26-064353, Size: 2 MB) reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure with no specific transaction details, financial metrics, dollar values, or period-over-period comparisons provided in the summary. No positive or negative quantitative impacts are disclosed.

• ·Filing Accession Number: 0001193125-26-064353
• ·Filing Size: 2 MB

23-02-2026

Organogenesis Holdings Inc. filed an 8-K on 2026-02-23 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative data such as compensation amounts are disclosed. No positive or negative metrics, comparisons, or scheduled events are mentioned.

23-02-2026

OLB Group, Inc. filed an 8-K on February 23, 2026, reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). This is a multi-item filing with no quantitative details on transaction values, financial impacts, or strategic implications disclosed in the provided information. No revenue, earnings, balance sheet effects, or guidance changes are mentioned.

23-02-2026

Vir Biotechnology, Inc. filed a multi-item Form 8-K on February 23, 2026, reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific transaction details, financial metrics, dollar values, share counts, or period-over-period comparisons are disclosed. The filing indicates potentially significant developments but provides no quantitative data for impact assessment.

23-02-2026

Willow Lane Acquisition Corp. II filed an 8-K on 2026-02-23 disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01 in connection with a merger/acquisition event. No specific deal structure, parties involved beyond the filer, valuation, financial terms, or quantitative metrics are disclosed in the filing summary provided. No positive or negative performance metrics are mentioned.

23-02-2026

AMC Networks Inc. filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or metrics (positive, negative, or flat) are disclosed. This multi-item filing signals a potentially significant development, but lacks quantitative data for assessment.

23-02-2026

HA Sustainable Infrastructure Capital, Inc. filed an 8-K on 2026-02-23 reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement, transaction value, parties, financial impacts, or other metrics are provided.

23-02-2026

Empire Petroleum Corp filed an 8-K on 2026-02-23 disclosing under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 2.03 unregistered sales of equity securities, with Item 9.01 providing financial statements and exhibits. No quantitative transaction values, financial impacts, or strategic details are disclosed. This is a multi-item mandatory filing with no specified positive or negative metrics.

23-02-2026

Interactive Strength, Inc. filed an 8-K on 2026-02-23 reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the agreement, events, or exhibits are disclosed. No financial metrics, positive or negative changes, or quantitative impacts are mentioned.

23-02-2026

TCW Strategic Income Fund Inc filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 8.01 Other Events. No specific details regarding the nature of the agreement, transaction size, financial impacts, or other quantitative metrics are disclosed in the provided filing summary. This represents a multi-item mandatory disclosure with no period-over-period comparisons or named entities beyond the filer mentioned.

23-02-2026

Lument Finance Trust, Inc. filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or other metrics are provided.

23-02-2026

SONIDA SENIOR LIVING, INC. filed an 8-K on February 23, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, or compensation amounts are provided.

23-02-2026

Armada Acquisition Corp. III filed an 8-K on February 23, 2026, disclosing under Item 1.01 entry into a material definitive agreement related to a merger/acquisition event. The filing also covers Item 3.02 unregistered sales of equity securities, Item 5.02 changes in directors or officers including compensatory arrangements, Item 5.03 amendments to articles of incorporation or bylaws, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific deal terms, financial metrics, target company, valuation, or quantitative data are disclosed.

23-02-2026

Lottery.com Inc. filed an 8-K on 2026-02-23 (AccNo: 0001493152-26-007783) disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.01 completion of an acquisition or disposition of assets. No financial terms, parties involved, deal valuation, strategic rationale, or other quantitative metrics are mentioned. The filing provides limited details on this completed transaction.